H.R. 5950

Improving Patient Access to Care and Treatment Act

Latest
Raw Text PDF XML

I

117th CONGRESS

1st Session

H. R. 5950

IN THE HOUSE OF REPRESENTATIVES

November 12, 2021

Ms. Dean (for herself, Mrs. Spartz, Ms. Scanlon, and Mr. Fitzpatrick) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to increase the number of days before which certain controlled substances for maintenance or detoxification treatment must be administered, and for other purposes.

1.

Short title

This Act may be cited as the Improving Patient Access to Care and Treatment Act.

2.

Increase in number of days before which certain controlled substances must be administered

Section 309A(a)(5) of the Controlled Substances Act (21 U.S.C. 829a(a)(5)) is amended by striking 14 days and inserting 60 days.